Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 1994; Volume 270,Issue 1
  • You have access
    Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein.
    B F Pan, A Dutt and J A Nelson
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 1-7;
  • You have access
    Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    J Bralet, C Marie, C Mossiat, J M Lecomte, C Gros and J C Schwartz
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 8-14;
  • You have access
    Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
    P J Bushnell, K L Kelly and T R Ward
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 15-25;
  • You have access
    Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.
    H L McLeod, L Fang, X Luo, E P Scott and W E Evans
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 26-29;
  • You have access
    Modulation of the acetylcholine- and substance P-induced pulmonary edema by calcitonin gene-related peptide in the rabbit.
    A Delaunois, P Gustin and M Ansay
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 30-36;
  • You have access
    Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice.
    Y Miyamoto, W D Bowen, P S Portoghese and A E Takemori
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 37-39;
  • You have access
    Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells.
    T Tang, J G Kiang and B M Cox
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 40-46;
  • You have access
    Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
    K Derakhchan, P Pagé, C Lambert and T Kus
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 47-54;
  • You have access
    Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary gland: possible involvement of ETA receptor activation and prostaglandin E2 production.
    M Domae, K Yamada, T Inoue, M Satoh and T Furukawa
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 55-60;
  • You have access
    Ethanol modulation of the gamma-aminobutyric acidA- and glycine-activated Cl- current in cultured mouse neurons.
    L G Aguayo and F C Pancetti
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 61-69;
  • You have access
    Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
    J R Atack, A M Prior, S R Fletcher, K Quirk, R McKernan and C I Ragan
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 70-76;
  • You have access
    Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    O Valverde, R Maldonado, M C Fournie-Zaluski and B P Roques
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 77-88;
  • You have access
    Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone.
    E Romeo, D L Cheney, I Zivkovic, E Costa and A Guidotti
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 89-96;
  • You have access
    Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    M Johnson, P K Sonsalla, A A Letter, G R Hanson and J W Gibb
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 97-103;
  • You have access
    Pharmacological evidence for regulation of Na(+)-Ca++ exchange by Ca++/calmodulin-dependent protein kinase in isolated bovine adrenal medullary cells.
    M Isosaki, N Minami and T Nakashima
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 104-110;
  • You have access
    An acute dose of desmethylimipramine inhibits brain uptake of [125I]3,3',5-triiodothyronine (T3) in thyroxine-induced but not T3-induced hyperthyroid rats: implications for tricyclic antidepressant therapy.
    J T Gordon, E E Tomlinson, J Greenberg and M B Dratman
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 111-117;
  • You have access
    Hemodynamic and cerebral blood flow effects of cocaine, cocaethylene and benzoylecgonine in conscious and anesthetized fetal lambs.
    R F Covert, M D Schreiber, I R Tebbett and L J Torgerson
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 118-126;
  • You have access
    Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
    C S Aulakh, P Mazzola-Pomietto, K M Wozniak, J L Hill and D L Murphy
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 127-132;
  • You have access
    Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    J M Masserano, D Venable and R J Wyatt
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 133-141;
  • You have access
    Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
    P J Winsauer, J F Verrees, K P O'Halloran, M A Bixler and P C Mele
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 142-149;
  • You have access
    Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    I M Khan, P Taylor and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 150-158;
  • You have access
    Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    I M Khan, T L Yaksh and P Taylor
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 159-166;
  • You have access
    Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
    A Berson, L Schmets, C Fisch, D Fau, C Wolf, B Fromenty, D Deschamps and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 167-176;
  • You have access
    Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    P L Prather, A W Tsai and P Y Law
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 177-184;
  • You have access
    Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase.
    S L Durham, C M Hare, M R Angelastro, J P Burkhart, J R Koehl, A L Marquart, S Mehdi, N P Peet and M J Janusz
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 185-191;
  • You have access
    Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    S P Gygi, J W Gibb and G R Hanson
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 192-197;
  • You have access
    Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    P A Scott, J M Chou, H Tang and A Frazer
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 198-208;
  • You have access
    Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.
    S B Caine and G F Koob
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 209-218;
  • You have access
    The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
    P B Smith, D R Compton, S P Welch, R K Razdan, R Mechoulam and B R Martin
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 219-227;
  • You have access
    Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
    M Clozel, V Breu, G A Gray, B Kalina, B M Löffler, K Burri, J M Cassal, G Hirth, M Müller and W Neidhart
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 228-235;
  • You have access
    Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
    P M Hellstrom, K S Murthy, J R Grider and G M Makhlouf
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 236-243;
  • You have access
    Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
    Y X Wang, G D Clarke, M Sbacchi, G Petrone and D P Brooks
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 244-249;
  • You have access
    Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    D C Underwood, C J Kotzer, S Bochnowicz, R R Osborn, M A Luttmann, D W Hay and T J Torphy
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 250-259;
  • You have access
    Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
    J W Ryan, F A Valido, M J Sequeira, A Y Chung, P Berryer, X L Chen and J D Catravas
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 260-268;
  • You have access
    Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries.
    R J Altiere, D C Travis, J Roberts and D C Thompson
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 269-276;
  • You have access
    Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
    G Cuadra, K Summers and E Giacobini
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 277-284;
  • You have access
    Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.
    K S Pang, F Barker, A J Schwab and C A Goresky
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 285-295;
  • You have access
    Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla and J B Wang
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 296-309;
  • You have access
    (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    S P Arneric, J P Sullivan, C A Briggs, D Donnelly-Roberts, D J Anderson, J L Raszkiewicz, M L Hughes, E D Cadman, P Adams and D S Garvey
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 310-318;
  • You have access
    (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    M W Decker, J D Brioni, J P Sullivan, M J Buckley, R J Radek, J L Raszkiewicz, C H Kang, D J Kim, W J Giardina and J T Wasicak
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 319-328;
  • You have access
    Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney.
    K Higaki, K Kadono, S Goto and M Nakano
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 329-335;
  • You have access
    Chronic ethanol exposure inhibits ATP-stimulated but not KCl-stimulated dopamine release in PC 12 cells.
    W K Kim, R G Johnson, L T Izu and R A Rabin
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 336-341;
  • You have access
    Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
    A Ohnishi, M Mihara, S Yasuda, Y Tomono, J Hasegawa and T Tanaka
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 342-347;
  • You have access
    Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
    R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen and R A Lubet
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 348-355;
  • You have access
    Enhanced elimination of biotinylated antibodies by avidin-based hemoperfusion in rats.
    K K Burkhart, D Beard and M L Billingsley
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 356-361;
  • You have access
    Quantitative autoradiography of [3H]t-butylbicycloorthobenzoate binding to the gamma-aminobutyric acid receptorA complex.
    S Y Sakurai, A Kume, D E Burdette and R L Albin
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 362-370;
  • You have access
    In vitro biotransformation of 1,1-dichloroethylene by hepatic cytochrome P-450 2E1 in mice.
    R P Lee and P G Forkert
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 371-376;
  • You have access
    N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P-450 in vivo.
    L C Knickle, R M Philpot and J R Bend
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 377-385;
  • You have access
    Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice.
    O Pol, I Ferrer and M M Puig
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 386-391;
  • You have access
    Fetoplacental growth and placental protein synthesis in rats after chronic maternal cocaine administration.
    A S Salhab, C L DeVane, T Medrano, W C Buhi, I R Tebbett and K T Shiverick
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 392-398;
  • You have access
    Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
    K M Metters, Y Gareau, A Lord, C Rochette and N Sawyer
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 399-406;
  • You have access
    Characterization of pyrazole and 4-methylpyrazole induction of cytochrome P4502E1 in rat kidney.
    D Wu and A I Cederbaum
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 407-413;
  • You have access
    Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
    T Shimada, H Yamazaki, M Mimura, Y Inui and F P Guengerich
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 414-423;
  • You have access
    The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats.
    T P Abrahams, P J Hornby, K Chen, A M Dasilva and R A Gillis
    Journal of Pharmacology and Experimental Therapeutics July 1994, 270 (1) 424-432;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 270, Issue 1
1 Jul 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics